Lupin announces achievement of key milestones for its clinical stage MEK inhibitor compound Read more
Boehringer Ingelheim India to sustain growth momentum in 2021, focuses on partnerships in NCD management Read more
Boehringer Ingelheim, Enara Bio sign pact to discover novel shared antigens for cancer immunotherapies Read more
ISMMS, Boehringer Ingelheim to test nintedanib for treating pulmonary fibrosis post-COVID-19 infection Read more
Bridge Biotherapeutics, Boehringer Ingelheim cancel agreement to develop BBT-877 for idiopathic pulmonary fibrosis Read more